Sarcoma
📧 Sign up to get email alerts when something new happens for Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor [Phase 1, Phase 2]
Multicohort Phase 1/2 clinical trial evaluating PM14 as monotherapy and in combination with radiotherapy for soft tissue sarcoma and other s…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Lipid Mediators & Cancer: Montelukast, SPM, and Almonds [EARLY_Phase 1]
This early Phase 1 clinical trial from the University of South Florida investigates montelukast, specialized pro-resolving mediators, and al…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST [Phase 3]
An update on a Phase 3 trial comparing three versus five years of adjuvant imatinib in patients with operable gastrointestinal stromal tumor…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
This clinical trial assesses the expression of Cadherin 6 (CDH6) in primary malignant bone tumors and investigates its potential use for pro…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma [Phase 2]
A phase 2 clinical trial evaluating a triple combination of Talimogene laherparepvec, Nivolumab, and Trabectedin for sarcoma is currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Ex VIvo DEtermiNed Cancer Therapy
An ongoing clinical trial for an Ex Vivo Determined Cancer Therapy is currently recruiting and spans multiple cancers, including bladder and…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma [Phase 2]
Clinical trial update for SM-88 as maintenance therapy in advanced Ewing's sarcoma and as salvage therapy for sarcoma (Phase 2); trial is cu…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: T2* MRI Analysis for Sarcoma
Completed clinical trial evaluating T2* MRI analysis in sarcoma patients undergoing radiotherapy.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) [Phase 2]
This Phase 2 clinical trial (Stereosarc) is evaluating stereotaxic body irradiation for oligometastases in sarcoma and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: BostonGene and Exigent Genomic INsight Study
Clinical trial update indicates that the BostonGene-Exigent Genomic INsight study is currently recruiting participants across indications in…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors [NA]
Ongoing recruitment for a clinical trial evaluating cryopreserved ovarian tissue transplantation in patients who have survived sarcomas and …
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Establishment of a Prospective Clinical-biological Database [NA]
A prospective clinical-biological database for sarcoma patients is being established under sponsor Institut du Cancer de Montpellier - Val d…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of Clinical and Biological Database [NA]
A clinical trial from Institut du Cancer de Montpellier - Val d'Aurelle is developing a clinical and biological database and is recruiting f…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-GD2 CAR T cells in pediatric patients with high-risk or relapsed/refractory neuroblastoma and other…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) [NA]
VALOROUS is a clinical trial evaluating locally ablative therapy for oligoprogressive solid tumors and is currently recruiting, including br…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Dendritic Cell Vaccination for Patients with Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical study evaluating a dendritic cell vaccine in patients with solid tumors, including glioblastoma and renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: TK216 in Patients With Relapsed or Refractory Ewing Sarcoma [Phase 1, Phase 2]
Clinical trial update for TK216 in relapsed or refractory Ewing sarcoma (Phase 1/2) shows the study was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults
A completed multicenter French population-based case-control study (Etiosarc) investigating environmental and occupational factors in adult …
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors [Phase 1]
A Phase I trial evaluating CCT303-406 in relapsed or refractory HER2-positive solid tumors is active but not recruiting, including gastric c…
-
CLINICAL_TRIALS withdrawal · 2024-10-28Clinical Trial Update: CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas [Phase 1]
Phase 1 clinical trial update for CCT301-38 CAR-T in relapsed or refractory AXl-positive sarcomas has been terminated.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors [Phase 2]
Phase 2 trial of AdAPT-001 in patients with sarcoma and refractory solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]
Phase 1 clinical trial evaluating the GD2-SADA:177Lu-DOTA complex in GD2-expressing solid tumors is currently recruiting, including small ce…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Physical Activity and Sarcoma, Role and Impact on Outcome
This update describes a planned clinical trial from the European Institute of Oncology to evaluate the role of physical activity on outcomes…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human study of oral TP-1287 in patients with advanced solid tumors, including specific sarcoma subtypes, has been terminate…